Displaying drugs 651 - 675 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Cabergoline | 451.6043 C26H37N5O2 |  | A dopamine receptor agonist used for the treatment of hyperprolactinemic conditions due to various causes. | Prolactine Inhibitors |
| Dibekacin | 451.521 C18H37N5O8 |  | Dibekacin is an aminoglycoside antibiotic marketed in Japan . | Anti-Bacterial Agents |
| Doxazosin | 451.4751 C23H25N5O5 |  | An alpha-1 adrenergic receptor used to treat mild to moderate hypertension and urinary obstruction due to benign prostatic hyperplasia. | Antihypertensive Agents |
| Magnesium citrate | 451.113 C12H10Mg3O14 |  | A laxative used in bowel preparation for colonoscopy or as a magnesium supplement. | Magnesium Compounds / Salt Solutions |
| Suvorexant | 450.93 C23H23ClN6O2 |  | A orexin receptor antagonist used to treat insomnia that is characterized by difficulties with sleep onset and/or sleep maintenance. | Orexin Receptor Antagonists / Sleep Aids, Pharmaceutical |
| Daridorexant | 450.93 C23H23ClN6O2 |  | A dual orexin receptor antagonist used to treat insomnia in adults. | Orexin Receptor Antagonists |
| Empagliflozin | 450.91 C23H27ClO7 |  | An SGLT2 inhibitor used to manage type 2 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Phylloquinone | 450.6957 C31H46O2 |  | A fat soluble vitamin used to treat hemorrhagic conditions in infants and coumarin overdoses. | Hemostatics |
| Magnesium gluconate | 450.629 C12H26MgO16 |  | A mineral supplement used to treat or prevent hypomagnesemia. | Magnesium Compounds |
| Mitapivat | 450.56 C24H26N4O3S |  | A pyruvate kinase activator used to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency. | Sulfonamides |
| Leniolisib | 450.466 C21H25F3N6O2 |  | A phosphoinositide 3-kinase-delta inhibitor that is used to treat activated phosphoinositide 3-kinase delta syndrome. | Adjuvants, Immunologic / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Kinase Inhibitor / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein substrates |
| Crizotinib | 450.337 C21H22Cl2FN5O |  | A receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Tedizolid phosphate | 450.323 C17H16FN6O6P |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Asciminib | 449.84 C20H18ClF2N5O3 |  | An inhibitor of ABL/BCR-ABL1 tyrosine kinase for the treatment of patients with Philadelphia chromosome-positive CML, including those with the T315I mutation. | Bcr-Abl Tyrosine Kinase Inhibitors / Tyrosine Kinase Inhibitors |
| Bictegravir | 449.386 C21H18F3N3O5 |  | An integrase inhibitor used to treat HIV infections. | Antiinfectives for Systemic Use / Antiviral Agents / Antivirals for Systemic Use / Antivirals used in combination for the treatment of HIV infections / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Direct Acting Antivirals / Heterocyclic Compounds, Fused-Ring / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor / MATE 1 Inhibitors / MATE inhibitors / Pyridines / UGT1A1 Substrates |
| Technetium Tc-99m disofenin | 449.321 C18H26N2O5Tc |  | A radiopharmaceutical diagnostic agent used for hepatobiliary scans. | Technetium (99Mtc) Compounds |
| Tolvaptan | 448.941 C26H25ClN2O3 |  | A selective vasopressin V2-receptor antagonist to slow kidney function decline in patients at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). Also used to treat hypervolemic and euvolemic hyponatremia. | Antidiuretic Hormone Receptor Antagonists / Benzazepines / Vasopressin V2 Receptor Antagonist |
| Aripiprazole | 448.385 C23H27Cl2N3O2 |  | An atypical antipsychotic used in the treatment of a wide variety of mood and psychotic disorders, such as schizophrenia, bipolar I, major depressive disorder, irritability associated with autism, and Tourette's syndrome. | Agents producing tachycardia / Agents that produce hypertension / Neurotoxic agents / Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome |
| Elvitegravir | 447.884 C23H23ClFNO5 |  | An antiretroviral agent used in combination with other antiretrovirals for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults. | Anti-HIV Agents / Anti-Retroviral Agents / HIV Integrase / Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor / Integrase Inhibitors |
| Palbociclib | 447.5328 C24H29N7O2 |  | An endocrine-based chemotherapeutic agent used in combination with other antineoplastic agents to treat HER2-negative and HR-positive advanced or metastatic breast cancer. | Cyclin-dependent kinase (CDK) inhibitors / Protein Kinase Inhibitors |
| Propyliodone | 447.011 C10H11I2NO3 |  | Radiopaque medium usually in oil; used in bronchography. | Non-Watersoluble X-Ray Contrast Media |
| Gefitinib | 446.902 C22H24ClFN4O3 |  | A tyrosine kinase inhibitor used as first-line therapy to treat non-small cell lung carcinoma (NSCLC) that meets certain genetic mutation criteria. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Hydrocortisone valerate | 446.5763 C26H38O6 |  | A corticosteroid used to treat inflammatory and pruritic corticosteroid-responsive dermatoses. | Corticosteroids |
| Trilaciclib | 446.559 C24H30N8O |  | A CDK4 and CDK6 inhibitor to reduce the risk of chemotherapy induced myelosuppression. | Detoxifying Agents for Antineoplastic Treatment |
| Erdafitinib | 446.555 C25H30N6O2 |  | A fibroblast growth factor receptor tyrosine kinase inhibitor used to treat locally advanced or metastatic urothelial carcinoma. | Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors |
Displaying drugs 651 - 675 of 2785 in total